dactinomycin has been researched along with erastin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, D; Eyupoglu, IY; Savaskan, N | 1 |
| Asperti, M; Codenotti, S; Fanzani, A; Marampon, F; Poli, M; Zizioli, D | 1 |
2 other study(ies) available for dactinomycin and erastin
| Article | Year |
|---|---|
Ferroptosis and Cell Death Analysis by Flow Cytometry.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Dactinomycin; Flow Cytometry; Humans; Indicators and Reagents; Iron; Necrosis; Niacinamide; Phenylurea Compounds; Piperazines; Propidium; Rats; Sorafenib | 2017 |
Cell growth potential drives ferroptosis susceptibility in rhabdomyosarcoma and myoblast cell lines.
Topics: Animals; Carbolines; Cell Death; Cell Line; Cell Line, Tumor; Cell Proliferation; Cyclohexylamines; Dactinomycin; Doxorubicin; Glutathione; Glutathione Peroxidase; Humans; Lipid Peroxidation; Mice; Myoblasts; Phenylenediamines; Piperazines; Rhabdomyosarcoma | 2018 |